We predicted that loss of aromatase function selectively within hematopoietic cells would lead to increased adiposity and impaired glucose tolerance, reproducing the metabolic phenotype of male mice with global aromatase deficiency. The gene discussed is CYP19A1; the disease is Impaired glucose tolerance.